Filter All News by:
Oct 21, 2021
NPR Academic Minute - "Follow-Up Care for Young Adult Cancer Survivors"
On University of California, Irvine Week: Lifelong follow up care is critical for young cancer survivors. Joel Milam, professor of epidemiology, examines why. Joel Milam, PhD, is a professor of epidemiology and biostatistics at the University of California, Irvine's Program in Public Health. He also has an adjunct appointment at the UCI School of Medicine's Department of Hematology/Oncology. Dr. Milam's research focuses on young adult cancer survivorship, positive psychology, and HIV prevention/control. Dr. Milam's interest in cancer research led him to become the Co-Leader of the Cancer Control Program at the Chao Family Comprehensive Cancer Center, where he facilitates research to identify and reduce cancer risk, and improve quality of life throughout the cancer care trajectory. Aside from teaching at UCI, Dr. Milam is a Co-Founder & Co-Director of the Center for Young Adult Cancer Survivorship Research. The Center is an interdisciplinary collaborative, including affiliate faculty, trainees, and patient advocates at UCI and USC.
Oct 20, 2021
NPR Academic Minute - "The Central Role of Social Support in the Health of Chinese and Korean American Immigrants"
Immigrants can thrive with a strong support network. Brittany Morey, assistant professor of health, society and behavior, explores why. Brittany N. Morey, PhD, MPH, is an Assistant Professor of Public Health at University of California, Irvine.
Oct 13, 2021
Survivor beats breast cancer, not once but twice
LeeAnn Brill first came to UCI Health in 2015 when she was diagnosed with a rare and aggressive cancer in her right breast. Determined to find the best care and most advanced treatments possible, the registered pharmacist used her considerable research skills.
Sep 27, 2021
John Wayne Cancer Foundation gift establishes new surgical oncology fellowship training program at UCI
A gift from the John Wayne Cancer Foundation will establish the John Wayne Cancer Foundation Endowed Chair in Surgical Oncology and also fund the UCI John Wayne Cancer Foundation Endowed Fellowship in Surgical Oncology at the UCI School of Medicine.
Sep 01, 2021
A Marine Bacteria Species Shows Promise for Curing an Aggressive Brain Cancer
Glioblastoma cells are especially adept at dividing quickly; an untreated tumor doubles in size in just two weeks. But that speed comes at a cost, and Bota hoped to take advantage of the cells’ vulnerability. The problem was that none of the available proteasome inhibitors could cross the blood-brain barrier to target glioblastomas where they bloom. Bota, who by then had started her own lab at the University of California, Irvine, found herself thinking about the Nereus presentation.
Aug 23, 2021
Disparities Affect Care of Young Adult Childhood Cancer Survivors in LA
Young adult childhood cancer survivors (CCS) in Los Angeles face age and ethnic disparities leading to inadequate follow-up care, a survey study suggests. The findings aren't globally generalizable "due to different healthcare access/systems/insurance factors," Dr. Joel Milam of the University of Southern California, Irvine, told Reuters Health by email.
Aug 19, 2021
Dad diagnosed with cancer receives life-saving stem cell transplant at UCI Health
Dr. Stefan O. Ciurea, a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center, said stem cell transplants aren’t readily available everywhere because it takes a huge team.
Aug 13, 2021
BTK Inhibitors Represent the Preferred Frontline Regimen in CLL
The majority of patients with newly diagnosed chronic lymphocytic leukemia (CLL) have better outcomes with BTK inhibitors compared with standard chemoimmunotherapy, making them the logical choice for frontline therapy, explained Susan O’Brien, MD, in a virtual presentation during the 2021 Pan Pacific Lymphoma Conference.
Aug 04, 2021
UCI receives $700K from the City of Santa Ana to support new initiatives for health literacy, address barriers to COVID-19 resources in vulnerable populations
Professor of epidemiology Sora Tanjasiri, DrPH, MPH, one of UCI’s two principal investigators (PIs) on the project, commented, “The City of Santa Ana’s investment shows their continued commitment to better understanding barriers to care and implementing real world strategies to improve the health and well-being of our county’s most vulnerable populations.”
Aug 02, 2021
UCI receives record $592 million in research funding for fiscal 2020-21
From cutting-edge research for advancing precision medicine to an innovative new effort for improving public water infrastructure to increase conservation, University of California, Irvine scholars, scientists and physicians are blazing new paths to help change the world. And their impact keeps growing. In fiscal 2020-21, which ended June 30, UCI received the most research funding in campus history: $592 million in grants and contracts.